Platelet-derived endothelial cell growth factor as a prognostic factor for radiotherapy outcome in patients with adenocarcinoma of the uterine cervix

Gynecologic Oncology

Volumn 89, Issue 3, 2003, Pages 414-419

  Ryu, Sang Young ^a   Oka, Kuniyuki ^b   Tsujii, Hirohiko ^b   Suzuki, Yoshiyuki ^c   Nakano, Takahashi ^c  

^a Korea Cancer Center Hospital   (South Korea)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; PD ECGF; Radiation; Survival; Uterine cervix; VEGF

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ADENOCARCINOMA; AGE DISTRIBUTION; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SURVIVAL TIME; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0038173772     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00081-7     Document Type: Article

References (29)

1. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
2. Folkman J., Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
3. Fidler I.J., Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 9:1994;185-188.
4. Maeda K., Chung Y.S., Ogawa Y., et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:1996;858-863.
5. Paley P.J., Staskus K.A., Gebhard K., Mohanraj D., Twiggs L.B., Ramakrishnan S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 80:1997;98-106.
6. Linderholm B., Tavelin B., Grankvist K., Henriksson R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol. 16:1998;3121-3128.
7. Ishigami S.I., Arii S., Furutani M., et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer. 78:1998;1379-1384.
8. Fontanini G., Boldrini L., Chine S., et al. Expression of vascular endothelial growth factor mRNA in non-small cell lung carcinomas. Br J Cancer. 79:1999;363-369.
9. Furukawa T., Yoshimura A., Sumizawa T., et al. Angiogenic factor. Nature. 356:1992;668.
10. Haraguchi M., Miyadera K., Uemura K., et al. Angiogenic activity of enzymes. Nature. 368:1994;198.
11. Fujiwaki R., Hata K., Iida K., Maede Y., Miyazaki K. Vascular endothelial growth factor expression in progression of cervical cancer correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis . Anticancer Res. 20:2000;1317-1322.
12. Koukourakis M.I., Giatromanolaki A., Kakolyris S., et al. Different pattern of stromal and cancer cell thymidine phosphorylase reactivity in non small cell lung cancer. Impact on tumor neoangiogenesis and survival. Br J Cancer. 77:1998;1696-1703.
13. Takahashi Y., Bucana C.D., Liu W., et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis role of infiltrating cells . J Natl Cancer Inst. 88:1996;1146-1151.
14. Tokumo K., Kodama J., Seki N., et al. Different angiogenic pathways in human cervical cancer. Gynecol Oncol. 68:1998;38-44.
15. Loncaster J.A., Cooper R.A., Logue J.P., Davidson S.E., Hunter R.D., West C.M.L. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer. 83:2000;620-625.
16. Tjalma W., Weyler J., Weyn B., et al. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer. Eur J Obstet Gynecol Rep Biol. 92:2000;251-257.
17. O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A.L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55:1995;510-513.
18. Saeki T., Takashima S., Hosokawa S., et al. Differential endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon. Int J Oncol. 8:1996;1105-1111.
19. Takahashi Y., Cleary K.R., Mai M., Kitadai Y., Bucana C.D., Ellis L.M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res. 2:1996;1679-1684.
20. Fujiwaki R., Hata K., Iida K., Maedae Y., Koike M., Miyazaki K. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer. Acta Obstet Gynecol Scand. 78:1999;728-734.
21. Fujimoto J., Sakaguchi H., Hirose R., Ichigo S., Tamaya T. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancer. Br J Cancer. 79:1999;1249-1254.
22. Shepherd J.H. Cervical and vulva cancer changes in FIGO definitions of staging . Br J Obstet Gynaecol Scand. 103:1996;405-406.
23. World Health Organization. International histological classification of tumours. Geneva: World Health Organization, 1969-1981, 2nd ed. Berlin: Springer-Verlag; 1988-present.
24. Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55:1995;3964-3968.
25. Obermair A., Bancher-Todesca D., Bilgi S., et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst. 89:1997;1212-1217.
26. Perez C.A., Kuske R.R., Camel H.M., et al. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 14:1988;613-621.
27. Toi M., Inada K., Hoshina S., Suzuki H., Konda S., Tominaga T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res. 1:1995;961-964.
28. Maeda K., Kang S.M., Ogawa M., et al. Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer. 74:1997;545-550.
29. O'Byrne K.J., Koukourakis M.I., Giatromanolaki A., et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer. 82:2000;1427-1432.